Tolcapone, bromocriptine, and Parkinson's disease

被引：25

作者：

Agid, Y

Destee, A

Durif, F

Montastruc, JL

Pollak, P

机构：

[1] HOP LILLE,LILLE,FRANCE

[2] HOP FONTMAURE,CHAMALIERES,FRANCE

[3] FAC MED TOULOUSE,TOULOUSE,FRANCE

[4] HOP NORD,GRENOBLE,FRANCE

来源：

LANCET | 1997年 / 350卷 / 9079期

关键词：

D O I：

10.1016/S0140-6736(05)63511-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：712 / 713

页数：2

共 5 条

[1] ACUTE EFFECTS OF COMT INHIBITION ON L-DOPA PHARMACOKINETICS IN PATIENTS TREATED WITH CARBIDOPA AND SELEGILINE [J].

DAVIS, TL ;

ROZNOSKI, M ;

BURNS, RS .

CLINICAL NEUROPHARMACOLOGY, 1995, 18 (04) :333-337

[2] Tolcapone improves motor function and reduces levodopa requirement in patients with Parkinson's disease experiencing motor fluctuations: A multicenter, double-blind, randomized, placebo-controlled trial [J].

Kurth, MC ;

Adler, CH ;

StHilaire, M ;

Singer, C ;

Waters, C ;

LeWitt, P ;

Chernik, DA ;

Dorflinger, EE ;

Yoo, K ;

Lieberman, AN ;

Brewer, M ;

SaintHilaire, M ;

Pery, LM ;

Thomas, C ;

Turpin, L ;

OBrien, CF ;

Seeberger, LC ;

Duncan, KL ;

Caviness, JN ;

Douglas, M ;

Wheeler, K ;

Riley, D ;

Rainey, P ;

Tanner, CM ;

Kelker, K ;

Lewis, P ;

Trosch, RM ;

Mistura, KL ;

Montgomery, EB ;

Lindsey, B ;

Weiner, W ;

Shulman, LM ;

Sheldon, C ;

Waters, CH ;

Welsh, M ;

Trugman, JM ;

Landow, ER ;

Pedder, SCJ ;

Shimon, GS ;

Magni, G .

NEUROLOGY, 1997, 48 (01) :81-87

[3] TREATMENT STRATEGIES FOR EXTENSION OF LEVODOPA EFFECT [J].

LEWITT, PA .

NEUROLOGIC CLINICS, 1992, 10 (02) :511-526

[4] CURRENT STATUS OF DOPAMINE AGONISTS IN PARKINSONS-DISEASE MANAGEMENT [J].

MONTASTRUC, JL ;

RASCOL, O ;

SENARD, JM .

DRUGS, 1993, 46 (03) :384-393

[5]

TOLOSA ES, 1994, NEUROLOGY, V44, pS35

← 1 →